相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
Yoon-Koo Kang et al.
LANCET ONCOLOGY (2022)
Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
Jae-Ho Cheong et al.
NATURE COMMUNICATIONS (2022)
Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing cells in renal cell cancer
Maxime Meylan et al.
IMMUNITY (2022)
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Kohei Shitara et al.
NATURE (2022)
The Role of Type-2 Conventional Dendritic Cells in the Regulation of Tumor Immunity
Yasuyuki Saito et al.
CANCERS (2022)
Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Reveals a Tissue-Resident Macrophage-Related Signature for Predicting Immunotherapy Response in Breast Cancer Patients
Zi-An Xia et al.
CANCERS (2022)
Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology
Tinyi Chu et al.
NATURE CANCER (2022)
Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better?
John H. Strickler et al.
CLINICAL CANCER RESEARCH (2021)
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation
Jaikumar Duraiswamy et al.
CANCER CELL (2021)
Tumor-infiltrating dendritic cell states are conserved across solid human cancers
Genevieve M. Gerhard et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2021)
Meta-analysis of tumor- and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition
Kevin Litchfield et al.
CELL (2021)
Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer
Myung-Giun Noh et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2021)
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
New insights into M1/M2 macrophages: key modulators in cancer progression
Jiuyang Liu et al.
CANCER CELL INTERNATIONAL (2021)
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong-Mu Sun et al.
LANCET (2021)
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Yelena Y. Janjigian et al.
LANCET (2021)
IGFBP2 regulates PD-L1 expression by activating the EGFR-STAT3 signaling pathway in malignant melanoma
Ting Li et al.
CANCER LETTERS (2020)
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma
Benjamin P. Fairfax et al.
NATURE MEDICINE (2020)
Tertiary lymphoid structures in cancer - considerations for patient prognosis
Luis Munoz-Erazo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Accurate estimation of cell composition in bulk expression through robust integration of single-cell information
Brandon Jew et al.
NATURE COMMUNICATIONS (2020)
Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease
Stephane Groulx et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)
Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients
Linnan Zhu et al.
IMMUNITY (2020)
Association of inflammatory biomarkers with clinical outcomes in nivolumab-treated patients with advanced hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial
Kohei Shitara et al.
JAMA ONCOLOGY (2020)
Lingering effects of chemotherapy on mature T cells impair proliferation
Rajat K. Das et al.
BLOOD ADVANCES (2020)
Benchmarking of cell type deconvolution pipelines for transcriptomics data
Francisco Avila Cobos et al.
NATURE COMMUNICATIONS (2020)
Systematic assessment of tissue dissociation and storage biases in single-cell and single-nucleus RNA-seq workflows
Elena Denisenko et al.
GENOME BIOLOGY (2020)
Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review
Marc Lecoultre et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
The International Cancer Genome Consortium Data Portal
Junjun Zhang et al.
NATURE BIOTECHNOLOGY (2019)
The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic
Alexander M. Frankell et al.
NATURE GENETICS (2019)
Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors
Jeffrey M. Conroy et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Clinical and Molecular Predictors of Response to Immune Checkpoint Inhibitors in Patients with Advanced Esophagogastric Cancer
Megan Greally et al.
CLINICAL CANCER RESEARCH (2019)
Beyond cDC1: Emerging Roles of DC Crosstalk in Cancer Immunity
Rajkumar Noubade et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tumor mutational burden quantification from targeted gene panels: major advancements and challenges
Laura Fancello et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Immuno-oncology drug development goes global
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
In vivo Differentiation of Human Monocytes
Alice Coillard et al.
FRONTIERS IN IMMUNOLOGY (2019)
Validation of computational determination of microsatellite status using whole exome sequencing data from colorectal cancer patients
Amanda Frydendahl Boll Johansen et al.
BMC CANCER (2019)
Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma
Qiming Zhang et al.
CELL (2019)
The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
Diane Damotte et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Bulk tissue cell type deconvolution with multi-subject single-cell expression reference
Xuran Wang et al.
NATURE COMMUNICATIONS (2019)
Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy
Willemieke P. M. Dijksterhuis et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2019)
Human Dendritic Cells: Their Heterogeneity and Clinical Application Potential in Cancer Immunotherapy
Thiago A. Patente et al.
FRONTIERS IN IMMUNOLOGY (2019)
Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression
Christoph Hafemeister et al.
GENOME BIOLOGY (2019)
The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy
Wenxiao Jia et al.
CANCER BIOLOGY & MEDICINE (2019)
Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors
Laleh Haghverdi et al.
NATURE BIOTECHNOLOGY (2018)
Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim et al.
NATURE MEDICINE (2018)
Human in vivo-generated monocyte-derived dendritic cells and macrophages cross-present antigens through a vacuolar pathway
Tsing-Lee Tang-Huau et al.
NATURE COMMUNICATIONS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing
Jesper L. V. Maag et al.
MOLECULAR CANCER RESEARCH (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Nextflow enables reproducible computational workflows
Paolo Di Tommaso et al.
NATURE BIOTECHNOLOGY (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Tertiary Lymphoid Structures in Cancer: Drivers of Antitumor immunity, immunosuppression, or Bystander Sentinels in Disease?
Emily Jayne Colbeck et al.
FRONTIERS IN IMMUNOLOGY (2017)
Oesophageal cancer
Elizabeth C. Smyth et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
1070PADAPTATION OF THE IMMUNE RELATED RESPONSE CRITERIA: IRRECIST
O. Bohnsack et al.
ANNALS OF ONCOLOGY (2017)
Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Nadeem Riaz et al.
CELL (2017)
Type I interferons suppress viral replication but contribute to T cell depletion and dysfunction during chronic HIV-1 infection
Liang Cheng et al.
JCI INSIGHT (2017)
Vitamin D3 regulates LAMP3 expression in monocyte derived dendritic cells
L. Malaguarnera et al.
CELLULAR IMMUNOLOGY (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Oxaliplatin-induced acute thrombocytopenia
Gokmen Umut Erdem et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2016)
A Single-Cell Transcriptomic Map of the Human and Mouse Pancreas Reveals Inter- and Intra-cell Population Structure
Maayan Baron et al.
CELL SYSTEMS (2016)
Unprimed, M1 and M2 Macrophages Differentially Interact with Porphyromonas gingivalis
Roselind S. Lam et al.
PLOS ONE (2016)
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger et al.
NATURE (2015)
Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients
Emanuela Romano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
Eliezer M. Van Allen et al.
SCIENCE (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Beifang Niu et al.
BIOINFORMATICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
Tom Waddell et al.
LANCET ONCOLOGY (2013)
Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity
Austin M. Dulak et al.
NATURE GENETICS (2013)
Monocytes and Macrophages in Cancer: Development and Functions
David M. Richards et al.
CANCER MICROENVIRONMENT (2013)
Evaluation of Ternary Mobile Phases for the Analysis of Carbonyl Compound Derivatives using High-Performance Liquid Chromatography
Duy Xuan Ho et al.
THESCIENTIFICWORLDJOURNAL (2011)
Continuing Rapid Increase in Esophageal Adenocarcinoma in England and Wales
Come Lepage et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Capecitabine and oxaliplatin for advanced esophagogastric cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor
Andrea Ladanyi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
NK-cell and T-cell functions in patients with breast cancer:: effects of surgery and adjuvant chemo- and radiotherapy
F. Mozaffari et al.
BRITISH JOURNAL OF CANCER (2007)
Oxaliplatin and capecitabine in patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction and gastric cardia: a phase II study from the North Central Cancer Treatment Group
A Jatoi et al.
ANNALS OF ONCOLOGY (2006)
Chemotherapy-induced neutropenia - Risks, consequences, and new directions for its management
J Crawford et al.
CANCER (2004)
Review article: Barrett's oesophagus and associated adenocarcinoma - a UK perspective
RC Fitzgerald
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2004)
分享论文
